G. Spenlehauer

发表

Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.

D. Bazile, C. Prud'homme, M. T. Bassoullet, 1995, Journal of pharmaceutical sciences.

Influence of coating agents on the degradation of poly(D,L-lactic acid) nanoparticles in model digestive fluids (USP XXII)

D. Bazile, G. Spenlehauer, M. Veillard, 1996 .

Degradation of poly(D,L-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII).

D. Bazile, G. Spenlehauer, M. Veillard, 1996, Biomaterials.

Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators.

D. Bazile, G. Spenlehauer, M. Veillard, 1996, Biomaterials.

Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization.

J. Benoit, G. Spenlehauer, M. Veillard, 1986, Journal of pharmaceutical sciences.

Stabilizers against heat-induced aggregation of RPR 114849, an acidic fibroblast growth factor (aFGF)

G. Spenlehauer, R. Mckean, C. M. Won, 1998 .

Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.

P. Couvreur, D. Bazile, G. Spenlehauer, 1993, Journal of biomedical materials research.

Peroral administration of 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs.

D. Bazile, G. Spenlehauer, M. Veillard, 1998, Journal of drug targeting.

Influence of size polydispersity on drug release from coated pellets

B. Leclerc, I. Husson, G. Spenlehauer, 1992 .

Biodegradable microparticles for delivery of polypeptides and proteins.

G. Spenlehauer, C. Thies, F. Spenlehauer-Bonthonneau, 1989, Progress in clinical and biological research.

Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system.

G. Spenlehauer, D. Labarre, A. Fischer, 1997, Biomaterials.

Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers

Michel Veillard, Thierry Verrecchia, D. Bazile, 1995 .

Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats.

C. Ropert, D. Bazile, M. Marlard, 1992, Biomaterials.

In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method.

J. Benoit, M. Vert, G. Spenlehauer, 1989, Biomaterials.

Bioresorbability and biocompatibility of aliphatic polyesters

S. M. Li, Suming Li, S. Li, 1992 .

Modelling of drug release from pellets coated with an insoluble polymeric membrane

B. Leclerc, I. Husson, G. Spenlehauer, 1991 .

Biodegradable cisplatiim microspheres prepared by the solvent evaporation method: Morphology and release characteristics

J. Benoit, M. Vert, G. Spenlehauer, 1988 .

Release of the fluorescent marker Prodan® from poly(D,L-lactic acid) nanoparticles coated with albumin or polyvinyl alcohol in model digestive fluids (USP XXII)

D. Bazile, G. Spenlehauer, M. Veillard, 1997 .

Percolation and Release of Cisplatin Loaded in Poly(lactide-co-glycolide) Microspheres for Chemoembolization

G. Spenlehauer, M. Deyme, J. Benoit, 1992 .